Chemotherapy with 5-fluorouracil and a platinum compound improves outcomes in metastatic small bowel adenocarcinoma

Cancer

Volumn 113, Issue 8, 2008, Pages 2038-2045

  Overman, Michael J ^a   Kopetz, Scott ^a   Wen, Sijin ^a   Hoff, Paulo M ^b   Fogelman, David ^a   Morris, Jeffrey ^a   Abbruzzese, James L ^a   Ajani, Jaffer A ^a   Wolff, Robert A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b HOSPITAL SÍRIO LIBANÊS   (Brazil)

Author keywords

Chemotherapy; Fluorouracil; Metastasis; Platinum; Small bowel adenocarcinoma; Survival

Indexed keywords

ALPHA INTERFERON; BEVACIZUMAB; CAPECITABINE; CARBOPLATIN; CISPLATIN; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; GEMCITABINE; IRINOTECAN; MITOMYCIN; MITOMYCIN C; OXALIPLATIN; PACLITAXEL; PLATINUM DERIVATIVE;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER CENTER; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; DISEASE FREE SURVIVAL; DRUG RESPONSE; DUODENUM; FEMALE; HUMAN; ILEUM; JEJUNUM; MALE; MEDICAL RECORD REVIEW; METASTASIS; METASTATIC SMALL BOWEL ADENOCARCINOMA; MONOTHERAPY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTION; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SMALL INTESTINE CARCINOMA; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR LOCALIZATION; UNITED STATES;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; HUMANS; INTESTINAL NEOPLASMS; INTESTINE, SMALL; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PLATINUM COMPOUNDS; RETROSPECTIVE STUDIES;

EID: 55749116332     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23822     Document Type: Article

References (25)

1. Chow JS, Chen CC, Ahsan H, Neugut AI. A population-based study of the incidence of malignant small bowel tumors: SEER, 1973-1990. Int J Epidemiol. 1996;25:722-728.
2. Weiss NS, Yang CP. Incidence of histologic types of cancer of the small intestine. J Natl Cancer Inst. 1987;78:653-656.
3. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin. 2006;56:106-130.
4. Howe JR, Karnell LH, Menck HR, Scott-Conner C. The American College of Surgeons Commission on Cancer and the American Cancer Society. Adenocarcinoma of the small bowel: review of the National Cancer Data Base, 1985-1995. Cancer. 1999;86:2693-2706.
5. Czaykowski P. Chemotherapy for small bowel adenocarcinoma (SBA): experience over a 10-year period at the BC Cancer Agency [abstract]. Presented at the American Society of Clinical Oncology 2004 Gastrointestinal Cancers Symposium, San Francisco, California, January 22-24, 2004. Abstract 109.
6. Dabaja BS, Suki D, Pro B, Bonnen M, Ajani J. Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients. Cancer. 2004;101:518-526.
7. Fishman PN, Pond GR, Moore MJ, et al. Natural history and chemotherapy effectiveness for advanced adenocarcinoma of the small bowel: a retrospective review of 113 cases. Am J Clin Oncol. 2006;29:225-231.
8. Rochlin DB, Smart CR, Silva A. Chemotherapy of malignancies of the gastrointestinal tract. Am J Surg. 1965;109:43-46.
9. Gibson MK, Holcroft CA, Kvols LK, Haller D. Phase II study of 5-fluorouracil, doxorubicin, and mitomycin C for metastatic small bowel adenocarcinoma. Oncologist. 2005;10:132-137.
10. Jigyasu D, Bedikian AY, Stroehlein JR. Chemotherapy for primary adenocarcinoma of the small bowel. Cancer. 1984;53:23-25.
11. de Gramont A, Figer A, Seymour M, et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol. 2000;18:2938-2947.
12. Webb A, Cunningham D, Scarffe JH, et al. Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer. J Clin Oncol. 1997;15:261-267.
13. Crawley C, Ross P, Norman A, Hill A, Cunningham D. The Royal Marsden experience of a small bowel adenocarcinoma treated with protracted venous infusion 5-fluorouracil. Br J Cancer. 1998;78:508-510.
14. Locher C, Malka D, Boige V, et al. Combination chemotherapy in advanced small bowel adenocarcinoma. Oncology. 2005;69:290-294.
15. Overman MJ, Chedid S, Morris J, et al. A phase II study of capecitabine and oxaliplatin (CAPOX) in metastatic adenocarcinoma of the small bowel or ampulla of Vater [abstract]. Presented at the American Society of Clinical Oncology 2007 Gastrointestinal Cancers Symposium, Orlando, Florida, January 19-21, 2007. Abstract 139.
16. Greene FL, Page DL, Fleming ID, et al, eds. AJCC Cancer Staging Manual, 6th ed. New York, NY: Springer-Verlag; 2002.
17. Abrahams NA, Halverson A, Fazio VW, Rybicki LA, Goldblum JR. Adenocarcinoma of the small bowel: a study of 37 cases with emphasis on histologic prognostic factors. Dis Colon Rectum. 2002;45:1496-1502.
18. Wu AH, Yu MC, Mack TM. Smoking, alcohol use, dietary factors and risk of small intestinal adenocarcinoma. Int J Cancer. 1997;70:512-517.
19. Bauer RL, Palmer ML, Bauer AM, Nava HR, Douglass HO Jr. Adenocarcinoma of the small intestine: 21-year review of diagnosis, treatment, and prognosis. Ann Surg Oncol. 1994;1:183-188.
20. Frost DB, Mercado PD, Tyrell JS. Small bowel cancer: a 30-year review. Ann Surg Oncol. 1994;1:290-295.
21. Sadeghi B, Arvieux C, Glehen O, et al. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer. 2000;88:358-363.
22. Overman MJ, Varadhachary GR, Lin E, et al. Final response data of a phase II study of capecitabine and oxaliplatin (CAPOX) in advanced adenocarcinoma of the small bowel or ampulla of Vater [abstract]. J Clin Oncol. 2008;26S. Abstract 4538.
23. Enzinger PC, Earle C, Zhu A, et al. Phase I dose-finding and pharmacologic study of cisplatin, irinotecan, and either capecitabine or infusional 5-FU in patients with advanced gastrointestinal malignancies [abstract]. Presented at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium, Hollywood, Florida, January 27-29, 2005. Abstract 28.
24. Goetz MP, Erlichman C, Windebank AJ, et al. Phase I and pharmacokinetic study of 2 different schedules of oxaliplatin, irinotecan, fluorouracil, and leucovorin in patients with solid tumors. J Clin Oncol. 2003;21:3761-3769.
25. Morgan DF, Busuttil RW. Primary adenocarcinoma of the small intestine. Am J Surg. 1977;134:331-333.//////